AI Chip Maker Cerebras Sets IPO Price Range at $115–$125 per Share

Cerebras’s $115‑$125 IPO price is far below NVDA’s current $215 level, so it will not directly create price pressure. However, the entry of a new competitor could increase competition in the AI‑chip segment, potentially causing a slight short‑term selling pressure. Technical indicators support a strong bullish trend, with the 20‑day SMA above the 50‑day SMA and the MACD above its signal line. The RSI is around 68, indicating an overbought region, but an abrupt drop at this level is not expected. Overall, a neutral effect on NVDA’s price is anticipated in the short term, with a small probability of a decline due to increased competition.

Cerebras’ proposed offering price of $115‑$125 is markedly lower than AMD’s $455 level, which could signal increased competition in the AI chip market, though it is unlikely to exert direct pricing pressure. The RSI sits at 81.6, indicating an overbought condition and a modest short‑term correction may be possible. Both the MACD and SMA indicators support an uptrend. Overall, the short‑term market impact is neutral, with a slight probability of a decline to be considered.

Cerebras’ proposed offering price of $115‑$125 suggests that competition in the AI‑chip market could intensify. ARM is currently trading below its 20‑ and 50‑day moving averages, with an RSI of 46—well outside over‑bought territory—yet momentum remains weak. The announcement may modestly heighten investors’ risk perception, potentially pushing the stock down 1‑2 % over the next 1‑3 days. However, ARM’s underlying fundamentals and sector‑wide growth expectations are likely to temper this impact. Overall, a slight decline is anticipated, but no major move is expected.

Cerebras’s $115‑$125 IPO price range is markedly below AVGO’s current $430 level, so no immediate price pressure is anticipated in the short term. Technical indicators support a short‑term bullish bias: the price sits above the 20‑ and 50‑day moving averages, the RSI hovers around 60, and the MACD remains above its signal line. Nonetheless, intensifying competition in the AI chip market could impede AVGO’s ability to concentrate on its AI segment. Consequently, market reaction is expected to stay neutral, though investors should keep a close eye on sector developments.